For Outstanding Innovations in Neuropsychopharmacology by an Individual or Group

Sponsored by Pfizer Canada inc.

The Innovations in Neuropsychopharmacology Research Award is designed to recognize innovative research in neuropsychopharmacology. The Award consists of $5,000 and a suitably engraved plaque. The Innovations in Neuropsychopharmacology Award shall be presented annually for work done primarily in Canada by Canadian scientists, unless there is, in view of the Awards Committee, no qualified nominee.

The decision of the Awards Committee will be based solely on the outstanding innovative nature of the work by an individual or a group as demonstrated by a single piece of research contributed over a number of years. The Awardee(s) is/are expected to give a lecture based on his/her/their research at the Annual Meeting of the CCNP, and to contribute a manuscript, based on the lecture, to the CCNP official journal, the Journal of Psychiatry & Neuroscience, not later than six months after the lecture.

Nomination for 2012 Innovations in Neuropsychopharmacology Research Award

The names of nominees should be received by the CCNP Secretariat by November 30th, 2011. Supporting documentation must be received by December 31, 2011. For each award, this documentation shall consist of:

1. A completed CCNP Innovations Award checklist, signed by the nominee.
2. A two-page summary prepared by the sponsor describing the nominee's work and its importance in furthering the field of neuropsychopharmacology.
3. Up to 5 manuscripts or reprints considered by the sponsor to be pertinent to the nomination and which highlight the nominee's work.
4. The nominee's curriculum vitae.
5. A brief biographical sketch of the candidate prepared by the sponsor.
6. A 250-word abstract for a paper that would be submitted to the Journal of Psychiatry & Neuroscience by the nominee, should he/she be awarded the prize.

Formal presentation of the Award will be made to the recipient during the Annual Meeting of the College.

Note: The Innovations in Neuropsychopharmacology Research Award may be given for basic research or clinical research in alternate years. The Award will be presented for clinical research or basic science research in alternate years.

Please send the name of the nominee and a short supporting letter addressed to:

Dr. Marco Leyton
CCNP President

* Please send one copy of the above electronically to the CCNP Secretariat at rmena@ualberta.ca.

Deadline for receipt of initial nomination and short supporting letter is November 30th, 2011.

2011 Innovations in Neuropsychopharmacology Research Award Winner

Congratulations to Dr. Moshe Szyf, the winner of the 2011 Innovations in Neuropsychopharmacology Research Award. Read Dr. Moshe Szyf's biography.

See the previous recipients of this award here.